About this trial

Participants may take part in this study if they are scheduled to undergo a surgery that meets the following: (1) traditional open surgery via laparotomy, (2) length of surgery \>3 hours, and (3) curative-intent surgical resection of a cancer in the stomach, pancreas, bile ducts, liver, or peritoneal surfaces. The purpose of this study is (1) to evaluate the feasibility of collecting blood samples prior to surgery, post-surgery and pre- music-assisted relaxation and imagery (MARI) intervention, and immediately post-MARI intervention and (2) to identify gene expression changes associated with MARI and explore their relationship with immediate changes in pain intensity. Participants will be in this study for the duration of their hospital admission for surgery.

Eligibility criteria

Qualifiers

Age 50 to 80

Able to speak and understand English

Scheduled to undergo a surgery meeting the following criteria: (1) traditional open surgery (not laparoscopic or robotic) via laparotomy (midline or subcostal incisions), (2) length of surgery >3 hours, and (3) curative-intent surgical resection of a cancer in the stomach, pancreas, bile ducts, liver, or peritoneal surfaces

Participant reports pain intensity of 4/10 or above to study staff on day 1 post-surgery or any other day post-surgery through discharge

Disqualifiers

Significant visual impairment that has not been corrected

Significant hearing impairment that has not been corrected

Significant cognitive impairment that would prevent participant from participating in the study

Trial design

Treatments tested in this trial

  • Music-assisted relaxation and imagery (MARI)

Treatment groups

20 Participants
are divided into 1 treatment group

Locations

1
University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center44106, ClevelandOhio, United States

Sponsors and collaborators

Case Comprehensive Cancer Center

Lead sponsor

National Center for Complementary and Integrative Health (NCCIH)

Collaborator